LE WE PMID CA
ADHD58ADHD

Addiction (BASKET)

ADHD

Atomoxetine

Attention (Neurophysiology)

Autism

Decision (Neurophysiology)

Endophenotype

Fetal alcohol syndrome

Guanfacin

Lisdexamfetamine

Modafinil

Prefrontal cortex

1999  
1
Attention deficit hyperactivity disorder--a review.
[10621994] Br J Gen Pract 49(444): 563-71 (1999)
2008  
2
Attention deficit hyperactivity disorder in adulthood: diagnosis, etiology and therapy.
[19629241] Dtsch Arztebl Int 105(17): 311-7 (2008)
2004  
3
Diagnostic controversies in adult attention deficit hyperactivity disorder.
[15514392] Am J Psychiatry 161(11): 1948-56 (2004)
2003  
4
Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
[14594733] Am J Psychiatry 160(11): 1909-18 (2003)
2009  
5
The restless brain: attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability.
[19835673] Can J Psychiatry 54(10): 665-72 (2009)
2009  
6
Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry.
[19835672] Can J Psychiatry 54(10): 651-64 (2009)
2009  
7
Comorbidity and neuroimaging in attention-deficit hyperactivity disorder.
[19835671] Can J Psychiatry 54(10): 649-50 (2009)
2001  
8
The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.
[15014618] Prim Care Companion J Clin Psychiatry 3(2): 66-77 (2001)
2008  
9
Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy.
[18793405] Child Adolesc Psychiatry Ment Health 2(1): 25 (2008)
2009  
10
Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).
[19761584] BMC Psychiatry 9(): 58 (2009)
2009  
11
A review of long-acting medications for ADHD in Canada.
[19881943] J Can Acad Child Adolesc Psychiatry 18(4): 331-9 (2009)
2009  
12
A clinical overview of sleep and attention-deficit/hyperactivity disorder in children and adolescents.
[19495429] J Can Acad Child Adolesc Psychiatry 18(2): 92-102 (2009)
2009  
13
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride.
[19721722] Neuropsychiatr Dis Treat 5(): 421-32 (2009)
2009  
14
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review.
[19557116] Neuropsychiatr Dis Treat 5(): 215-26 (2009)
2008  
15
Treatment of adults with attention-deficit/hyperactivity disorder.
[18728745] Neuropsychiatr Dis Treat 4(2): 389-403 (2008)
2008  
16
Treatment of adults with attention-deficit/hyperactivity disorder.
[18728812] Neuropsychiatr Dis Treat 4(1): 107-21 (2008)
2007  
17
A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents.
[19300563] Neuropsychiatr Dis Treat 3(3): 293-301 (2007)
2004  
18
Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
[15303310] Neural Plast 11(1-2): 133-49 (2004)
2004  
19
Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling.
[15303308] Neural Plast 11(1-2): 97-114 (2004)
2004  
20
Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD.
[15303307] Neural Plast 11(1-2): 77-95 (2004)
2009  
21
Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.
[19549202] Dev Med Child Neurol 51(8): 580-92 (2009)
2007  
22
Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.
[18078429] CNS Drug Rev 13(4): 465-74 (2007)
2008  
23
Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders.
[19037178] CNS Spectr 13(11): 977-84 (2008)
2010  
24
Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults.
[20448522] CNS Spectr 15(5): 315-25 (2010)
2009  
25
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
[19883527] Health Technol Assess 13(50): iii-iv, ix-xi, 1-120 (2009)
2004  
26
New options in the pharmacological management of attention-deficit/hyperactivity disorder.
[15352538] Am J Manag Care 10(4 Suppl): S117-24 (2004)
2004  
27
Attention-deficit/hyperactivity disorder: medication treatment-dosing and duration of action.
[15352536] Am J Manag Care 10(4 Suppl): S99-106 (2004)
2004  
28
Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
[15352535] Am J Manag Care 10(4 Suppl): S89-98 (2004)
2004  
29
New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
[15352534] Am J Manag Care 10(4 Suppl): S87-8 (2004)
2006  
30
Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities?
[16990360] Arch Dis Child 91(10): 860-1 (2006)
1994  
31
Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review.
[8031743] J Psychiatry Neurosci 19(3): 193-201 (1994)
2008  
32
Etiologic classification of attention-deficit/hyperactivity disorder.
[18245408] Pediatrics 121(2): e358-65 (2008)
2005  
33
Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
[15930238] Pediatrics 115(6): 1734-46 (2005)
2005  
34
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
[15930203] Pediatrics 115(6): e749-57 (2005)
2001  
35
Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.
[11581465] Pediatrics 108(4): 1033-44 (2001)
2001  
36
Attention deficit hyperactivity disorder.
[11527851] West J Med 175(3): 189-93 (2001)
1979  
37
The clinical physiology of water metabolism. Part I: The physiologic regulation of arginine vasopressin secretion and thirst.
[394480] West J Med 131(5): 373-400 (1979)
2003  
38
Assessment and management of attention-deficit hyperactivity disorder in adults.
[12642429] CMAJ 168(6): 715-22 (2003)
2001  
39
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.
[11762571] CMAJ 165(11): 1475-88 (2001)
2010  
40
Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.
[20359266] Altern Med Rev 15(1): 15-32 (2010)
2007  
41
EEG biofeedback in the treatment of attention deficit hyperactivity disorder.
[17604459] Altern Med Rev 12(2): 146-51 (2007)
2008  
42
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
[18427125] Circulation 117(18): 2407-23 (2008)
2008  
43
Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.
[18591484] Ann N Y Acad Sci 1129(-): 236-45 (2008)
2008  
44
ADHD in children and adolescents.
[19445793] Clin Evid (Online) 2008(-): - (2008)
2004  
45
Attention deficit hyperactivity disorder in adulthood.
[15026486] J Neurol Neurosurg Psychiatry 75(4): 523-5 (2004)
2008  
46
Recent developments in the psychosocial treatment of adult ADHD.
[18928346] Expert Rev Neurother 8(10): 1537-48 (2008)
2011  
47
Advances in understanding and treating ADHD.
[21658285] BMC Med 9(-): 72 (2011)
2010  
48
Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines.
[20856914] Neuropsychiatr Dis Treat 6(-): 509-15 (2010)
2011  
49
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation.
[21326653] Neuropsychiatr Dis Treat 7(-): 31-8 (2011)
2010  
50
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.
[20520740] Neuropsychiatr Dis Treat 6(-): 273-9 (2010)
2010  
51
Attention-deficit/hyperactivity disorder and attention networks.
[19759528] Neuropsychopharmacology 35(1): 278-300 (2010)
2009  
52
Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.
[18789354] Neurosci Biobehav Rev 33(5): 690-8 (2009)
2005  
53
Are we ready for endophenotypes in attention deficit hyperactivity disorder?
[16358104] Rev Bras Psiquiatr 27(4): 262-3 (2005)
2008  
54
Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.
[18295156] Child Adolesc Psychiatr Clin N Am 17(2): 459-74, xi (2008)
2010  
55
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review.
[19633992] Eur Child Adolesc Psychiatry 19(2): 83-105 (2010)
2010  
56
Molecular genetics of attention-deficit/hyperactivity disorder: an overview.
[20145962] Eur Child Adolesc Psychiatry 19(3): 237-57 (2010)
2011  
57
Preferences related to attention-deficit/hyperactivity disorder and its treatment.
[21311700] Patient Prefer Adherence 5(-): 33-43 (2011)
2008  
58
Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.
[18844482] J Child Adolesc Psychopharmacol 18(5): 413-47 (2008)
2010  
59
Molecular genetics of attention deficit hyperactivity disorder.
[20159345] Psychiatr Clin North Am 33(1): 159-80 (2010)
2009  
60
The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.
[19698722] Neuropharmacology 57(7-8): 619-26 (2009)
2007  
61
The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.
[17667893] CNS Spectr 12(8 Suppl 12): 1-14; quiz 15-6 (2007)
2007  
62
Lisdexamfetamine dimesylate: the first prodrug stimulant.
[20532026] Psychiatry (Edgmont) 4(8): 39-45 (2007)
2011  
63
Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
[22074258] BMC Psychiatry 11(-): 176 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Hyperkinetische Störungen (F90)
  • Aufmerksamkeitsstörungen: Diagnostik und Therapie


  • Search PubMed and many other databases on the combined search terms

    GG: adhd
    GG: attention-deficit hyperactivity disorder

  • ADHD

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia